Key Points
- Intuitive Surgical EVP Brian Edward Miller sold 3,500 shares on November 10 at an average price of $575 for total proceeds of $2,012,500, reducing his direct holdings to 5,758 shares (a 37.81% drop), according to an SEC filing.
- The stock trades near $572.45 with a market cap of $205.21 billion and a P/E of 75.72; the company recently beat quarterly expectations with EPS $2.40 vs $1.99 and revenue of $2.51 billion (up 22.9% year-over-year), and analysts' consensus target is about $608.92.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Myriam Curet sold 105 shares of the firm's stock in a transaction on Monday, November 10th. The stock was sold at an average price of $560.00, for a total value of $58,800.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Myriam Curet also recently made the following trade(s):
- On Tuesday, October 28th, Myriam Curet sold 7,562 shares of Intuitive Surgical stock. The stock was sold at an average price of $548.43, for a total value of $4,147,227.66.
- On Wednesday, October 29th, Myriam Curet sold 125 shares of Intuitive Surgical stock. The stock was sold at an average price of $543.00, for a total transaction of $67,875.00.
Intuitive Surgical Trading Down 0.4%
Shares of NASDAQ ISRG traded down $2.00 during midday trading on Thursday, hitting $570.45. The company's stock had a trading volume of 332,927 shares, compared to its average volume of 2,115,653. The stock has a fifty day moving average price of $478.64 and a 200 day moving average price of $502.49. The firm has a market capitalization of $204.49 billion, a price-to-earnings ratio of 75.36, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business's quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.84 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Intuitive Surgical
Institutional investors and hedge funds have recently made changes to their positions in the business. Aaron Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider's stock valued at $1,374,000 after purchasing an additional 19 shares during the period. J. W. Coons Advisors LLC lifted its holdings in Intuitive Surgical by 1.4% in the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider's stock worth $741,000 after buying an additional 20 shares during the period. Exencial Wealth Advisors LLC grew its position in shares of Intuitive Surgical by 3.1% in the 1st quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider's stock worth $327,000 after buying an additional 20 shares during the last quarter. Evergreen Capital Management LLC increased its stake in shares of Intuitive Surgical by 0.5% during the first quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider's stock valued at $2,124,000 after buying an additional 20 shares during the period. Finally, Rise Advisors LLC raised its holdings in shares of Intuitive Surgical by 5.6% during the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider's stock valued at $187,000 after acquiring an additional 20 shares in the last quarter. Institutional investors own 83.64% of the company's stock.
Analyst Ratings Changes
Several brokerages have commented on ISRG. Wall Street Zen downgraded shares of Intuitive Surgical from a "buy" rating to a "hold" rating in a report on Saturday, November 8th. Wells Fargo & Company lifted their price target on Intuitive Surgical from $599.00 to $600.00 and gave the company an "overweight" rating in a research report on Wednesday, October 22nd. Evercore ISI upped their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. HSBC boosted their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a "buy" rating in a research note on Thursday, October 23rd. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $608.92.
View Our Latest Stock Analysis on ISRG
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
